论文部分内容阅读
目的分析急诊绿色通道下血管内介入灌注治疗急性缺血性脑血管病的临床疗效。方法 120例急性缺血性脑血管病患者随机分为对照组(非绿色通道组)和观察组(绿色通道组),各60例。比较两组患者的疾病相关时间和脑缺血再灌注损伤情况。结果观察组患者急诊室-治疗结束时间(DTTE)、急诊室-导管室时间(DTL)、急诊室-会诊时间(DTC)时间为(111.2±14.6)、(52.8±13.6)、(6.6±2.7)min短于对照组(150.5±15.2)、(79.6±9.3)、(12.5±6.8)min,脑缺血再灌注损伤发生率为0低于对照组16.7%,差异均具有统计学意义(P<0.05)。结论急性缺血性脑血管病患者在绿色通道模式下进行血管内介入灌注治疗,急诊救治时间缩短,脑缺血再灌注损伤发生率降低,其临床疗效安全可靠,应值得进一步运用和推广。
Objective To analyze the clinical efficacy of intravascular perfusion in emergency treatment of acute ischemic cerebrovascular disease under emergency green channel. Methods 120 patients with acute ischemic cerebrovascular disease were randomly divided into control group (non-green channel group) and observation group (green channel group), each 60 patients. The disease-related time and cerebral ischemia-reperfusion injury were compared between the two groups. Results In the observation group, the emergency room-DTT, DTL, and DTC time were (111.2 ± 14.6), (52.8 ± 13.6), (6.6 ± 2.7) ) min was shorter than that in the control group (150.5 ± 15.2), (79.6 ± 9.3) and (12.5 ± 6.8) min, and the incidence of cerebral ischemia-reperfusion injury was 0 less than that of the control group (16.7%, P <0.05). Conclusion The patients with acute ischemic cerebrovascular disease are treated with intravascular perfusion in the green channel mode. The emergency treatment time is shortened and the incidence of cerebral ischemia-reperfusion injury is reduced. The clinical efficacy is safe and reliable and should be further used and promoted.